AMED: Japan Agency for Medical Research and Development

  • Japanese
  • English
Site search
  • Contact Us
  • Access
  • About AMED
  • Programs
  • Achievements
  • News
  • AMED is supporting R&D projects on
    the novel coronavirus disease (COVID-19).

    Click here for details
  • Our goal is to fast-track medical R&D
    that directly benefits people,
    not only by extending lifespans,
    but also by improving quality of life.

  • Your front-row seat to the best
    Japanese medical science ideas
    Become an AMED grant reviewer today.

    Click here for details
  • Our goal is to fast-track medical R&D
    that directly benefits people,
    not only by extending lifespans,
    but also by improving quality of life.

What's New

  • Calls for Proposals
  • Other
  • 05/19/22
    FY 2022 [Science and Technology Research Partnership for Sustainable Development (SATREPS)]
  • 05/18/22
    FY 2022 (Update)Interstellar Initiative
  • 05/16/22
    FY 2022 (Update)Advanced Research and Development Programs for Medical Innovation (AMED-CRES...
  • More News
  • 11/12/21
    Unveiling the Landscape of Genomic Alterations in Adult T-Cell Leukemia/Lymphoma - A Demonstration of the Potent...
  • 10/13/21
    AMED International Joint Symposium 2021: Promotion of Infectious Disease Research Cooperation between Africa and...
  • 10/11/21
    Molecular landscape of multi-step virus carcinogenesis revealed by multi-modal single-cell analysis
  • More News

News Release & Research Results

  • 05/19/22
    New SATREPS Projects for FY 2022 under AMED International Collaborative Research Program
  • 04/20/22
    Proposing a new concept that integrates species evolution and genetic evolution
  • 03/28/22
    Comparison of clonal architecture between primary and immunodeficient mouse engrafted acute myeloid leukemia cel...
  • More News

content

  • Overview

    Introduction of AMED

  • Achievements

    Introducing the results related to the programs that AMED's supports R&D

  • Intellectual Property

    Protection and exploitation of intellectual property

  • Research Integrity

    AMED promotes the measures in its Department of Research Integrity and Legal Affairs to ensure the fair and appropriate conducting of research

  • Collaboration / cooperation with external institutions

    Collaboration / Cooperation with External Organizations

  • Brochure

    Overview of the AMED, and selected programs summary etc.

  • Patient and Public Involvement (PPI)

    Information on Patient and Public  Involvement(PPI) in AMED

Top
  • Notes on use
  • Social media policy
  • Regarding the Handling of Personal Information on the Website
  • Intellectual Property
  • SiteMap
  • Japan Corporate Number (JNC):9010005023796
  • Japan Agency for Medical Research and Development
  • 1-7-1 Otemachi, Chiyoda-ku, Tokyo 100-0004 Japan

Copyright © Japan Agency for Medical Research and Development, All Rights Reserved.